Final review from kelli's notes Flashcards

1
Q

What are factors that affect absorption?

A

lipid solubility,
molecular weight,
ionization of drug (pKa),
route of administration,
stomach acid, first pass effect, food content in stomach,
whether the drug is a quaternary ammonium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a quatronary amonium? What are the implications of this?

A

A quatronary amonium is a drug that is polar, so it stays where it is given. For example, when inhaled, it stays in the lungs meaning it only causes local affects, but this also means that if they reach the bloodstream, they won’t get out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Factors that affect distribution

A

cardiac output
type of capillary/tissue perfusion
protein binding
polarity of drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What can metabolism do to a drug

A

activate or deactivate it
increased/decreased potency
alteration of toxicity
INCREASED RENAL EXCRETION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

potency

A

drug amont required to induce clinical effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

efficacy

A

ability of drug at a specific dose to induce a clinical effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Theraputic window

A

toxic effect - minimum theraputic concentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

toxicity

A

drug concentration that induces untoward adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which requires a higher dose, a drug that is more potent or a drug that is less potent?

A

less potent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which can induce a STRONGER clinical effect, a drug that is more potent or a drug that is less potent?

A

Neither, potency does not impact efficacity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

dose response curve

A

as dose increases, response increases, but only to a point, this plateau is the efficacity of the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Mechanisms of drug-drug interactions

A

any PK or PD principle or direct interactions
ex CYP450, absorption, PB competition, MAO inhibition, competition/synergy at receptor site, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What to do if teratogenic medication?

A

We don’t want the pt to abruptly stop their medication, they should use birth control and avoid getting pregnant until an alternative can be discussed and implemented

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Considerations for an elderly population

A

polypharmacy (many specialists)
DECREASED RENAL PERFUSION
for SOME elderly pts issues with reading/remembering to take meds can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Considerations with neonates

A

decreased renal and liver function
immature BBB
higher body water – increased Vd for water-soluble and decreased for fat-soluble

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does MAO A do?

A

breaks down NE and serotonin

17
Q

What does MAO B do?

A

breaks down dopamine

18
Q

AE of MAOI

A

HTN, possibly serotonin syndrome

19
Q

Where are MAO and COMT located? And what does COMT break down?

A

COMT breaks down dopamine, E and NE
MAO: Mostly presynaptic terminal
COMT: Mostly liver, some free

20
Q

Explain baroreceptor reflex. Where is it and what does it do? List some drug classes that
may elicit a baroreceptor response

A

The baroreceptor reflex is controlled by presure receptors in the carotid sinus and the aortic arch. When blood pressure gets too low, these receptors induce tachycardia, when it gets too high, bradycardia in order to control BP
hydralazine, dihydropyridines, a1 agonists, albuterol, phenylephrine - basically anything that alters arterial vascular pressure

21
Q

A1 agonism causes

A

vasoconstriction, prostate contraction (BPH symptoms increase)

22
Q

A2 agonism causes

A

platelet aggregation, decreased SNS outflow, presynaptic inhibition of NE release

23
Q

B1 agonism causes

A

increased HR, contractility, AV node conduction velocity. Renin release

24
Q

B2 agonism causes

A

bronchodilation, skeletal m/heart/lung vasodilation, decreased GI/GU motility increased K+ uptake, tremor, glycogenolysis (release of stored glucose)